国产99久久精品_欧美日本韩国一区二区_激情小说综合网_欧美一级二级视频_午夜av电影_日本久久精品视频

加拿大逸仕生物技術(shù)Anogen     
Yes Biotech Laboratories Ltd. ( 加拿大逸仕生物技術(shù)研究有限公司) 創(chuàng)建于1989年, 位于加拿大多倫多近郊的著名高科技城市密西沙加市。Anogen是加拿大逸士生物技術(shù)研究有限公司在國際上的市場經(jīng)銷部門。

十八余年來，Anogen-Yes Biotech Laboratories Ltd.研發(fā)和生產(chǎn)各種新穎抗體及有關(guān)產(chǎn)品，應(yīng)用廣泛的技術(shù)平臺設(shè)計和開發(fā)各種單克隆抗體、多克隆抗體、基因工程/人源化抗體、免疫檢驗用配對抗體、免疫球蛋白、活性多肽、酶聯(lián)免疫試劑盒[ELISA]、斑點酶聯(lián)免疫試劑盒[Elispots]和基因重組蛋白質(zhì)等等。 這些 產(chǎn)品主要用于生命科學(xué)研究和各種疾病的診斷和防治,包括炎癥和自身免疫性疾病、心血管病和癌癥等。

Anogen-Yes Biotech Laboratories Ltd.是北美地區(qū)最早獲得ISO 9001和ISO 13485 (Medical Devices) 證書的主要生物技術(shù)專業(yè)公司之一。 Anogen-Yes Biotech Laboratories Ltd.的數(shù)百種單克隆抗體、多克隆抗體、基因工程/人源化抗體, 以及數(shù)十種酶聯(lián)免疫試劑盒和斑點酶聯(lián)免疫試劑盒等其它產(chǎn)品都是在ISO 13485 嚴(yán)格質(zhì)量控制標(biāo)準(zhǔn)下進(jìn)行研制和生產(chǎn), 并以公認(rèn)的優(yōu)質(zhì)產(chǎn)品行銷全世界。 Anogen-Yes Biotech Laboratories Ltd. 是許多著名醫(yī)學(xué)研究中心、制藥公司、抗體和生物公司以及國際臨床試驗中心的供應(yīng)商。

Anogen-Yes Biotech Laboratories Ltd. 熱誠歡迎新顧客，亦歡迎與有關(guān)同行進(jìn)行技術(shù)交流，參觀考察、洽談知識產(chǎn)權(quán)轉(zhuǎn)讓及有關(guān)戰(zhàn)略聯(lián)盟和伙伴關(guān)系，以共同開發(fā)新產(chǎn)品，為生命科學(xué)發(fā)展作出貢獻(xiàn)。
 Anogen is the trade name of Yes Biotech Laboratories Ltd., a Canadian-based biopharmaceutical company located near Toronto that has been producing antibody products for research applications for nearly twenty years. Our broad technology platform enables us to design and develop a variety of products including monoclonal and polyclonal antibodies, immunoassay/ELISA kits, matched antibody pairs, immunoglobulins, hybridomas, bioactive peptides, ELISpots and recombinant proteins.

Our very popular monoclonal antibodies and ELISA kits, along with our polyclonal antibodies, matched antibody pairs, immunoglobulins, and all other antibody products manufactured by Anogen endure stringent quality testing that is reflected in their performance, reproducibility, efficiency and efficacy. Anogen distributes its antibody products worldwide and is a recognized quality supplier to many large antibody syndicates and suppliers.

We are committed to developing and commercializing antibody-related therapeutics and diagnostics to combat various diseases including inflammatory and autoimmune disorders, cardiovascular diseases and cancer.